Mirum Pharmaceuticals IncNASDAQ:MIRM
- LAST PRICE46.2200
- TODAY'S CHANGE (%)-0.4300 (-0.9218%)
- Bid / Lots44.7200/ 1
- Ask / Lots47.8900/ 1
- Open / Previous Close46.5600 / 46.6500
- Day Range
- 52 Week Range
- Volume206,870
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MIRM |
|---|---|---|
| 09:32 ET | 13483 | 46.5 |
| 09:33 ET | 200 | 46.22 |
| 09:35 ET | 1471 | 46.555 |
| 09:37 ET | 346 | 46.2881 |
| 09:39 ET | 226 | 46.2901 |
| 09:42 ET | 311 | 46.67 |
| 09:44 ET | 2872 | 47.04 |
| 09:46 ET | 9402 | 46.915 |
| 09:48 ET | 500 | 46.55 |
| 09:50 ET | 1146 | 46.515 |
| 09:51 ET | 1828 | 46.53 |
| 09:53 ET | 497 | 46.4 |
| 09:57 ET | 163 | 46.4174 |
| 10:00 ET | 200 | 46.325 |
| 10:02 ET | 1091 | 46.59 |
| 10:04 ET | 2199 | 46.805 |
| 10:06 ET | 1544 | 46.94 |
| 10:08 ET | 3100 | 47.05 |
| 10:09 ET | 1200 | 46.6014 |
| 10:11 ET | 1105 | 46.56 |
| 10:13 ET | 702 | 46.79 |
| 10:15 ET | 317 | 46.82 |
| 10:18 ET | 1041 | 46.78 |
| 10:20 ET | 236 | 46.5122 |
| 10:22 ET | 263 | 46.4735 |
| 10:24 ET | 631 | 46.62 |
| 10:26 ET | 1087 | 46.6 |
| 10:27 ET | 829 | 46.635 |
| 10:29 ET | 165 | 46.4795 |
| 10:31 ET | 482 | 46.63 |
| 10:33 ET | 100 | 46.64 |
| 10:36 ET | 691 | 46.5401 |
| 10:40 ET | 740 | 46.625 |
| 10:44 ET | 391 | 46.5033 |
| 10:47 ET | 140 | 46.4774 |
| 10:49 ET | 713 | 46.63 |
| 10:51 ET | 214 | 46.5787 |
| 10:54 ET | 322 | 46.5779 |
| 10:58 ET | 200 | 46.62 |
| 11:00 ET | 367 | 46.56 |
| 11:02 ET | 784 | 46.585 |
| 11:03 ET | 100 | 46.62 |
| 11:05 ET | 295 | 46.5598 |
| 11:09 ET | 478 | 46.5532 |
| 11:12 ET | 230 | 46.5401 |
| 11:14 ET | 479 | 46.41 |
| 11:16 ET | 300 | 46.4 |
| 11:20 ET | 287 | 46.32 |
| 11:21 ET | 300 | 46.16 |
| 11:25 ET | 623 | 46.3 |
| 11:27 ET | 300 | 46.27 |
| 11:30 ET | 100 | 46.28 |
| 11:32 ET | 502 | 46.3 |
| 11:34 ET | 200 | 46.34 |
| 11:36 ET | 300 | 46.24 |
| 11:38 ET | 328 | 46.2039 |
| 11:39 ET | 893 | 46.175 |
| 11:41 ET | 300 | 46.2 |
| 11:43 ET | 203 | 46.1872 |
| 11:45 ET | 323 | 46.17 |
| 11:48 ET | 100 | 46.2 |
| 11:52 ET | 200 | 46.155 |
| 11:54 ET | 400 | 46.19 |
| 11:59 ET | 100 | 46.13 |
| 12:03 ET | 100 | 46.16 |
| 12:06 ET | 900 | 46.17 |
| 12:08 ET | 100 | 46.25 |
| 12:10 ET | 100 | 46.24 |
| 12:12 ET | 1470 | 46.09 |
| 12:14 ET | 324 | 46.09 |
| 12:17 ET | 300 | 46.15 |
| 12:19 ET | 300 | 46.09 |
| 12:21 ET | 100 | 46.15 |
| 12:24 ET | 100 | 46.18 |
| 12:28 ET | 1502 | 46.16 |
| 12:30 ET | 1238 | 46.25 |
| 12:33 ET | 300 | 46.38 |
| 12:35 ET | 100 | 46.42 |
| 12:37 ET | 732 | 46.3401 |
| 12:42 ET | 200 | 46.39 |
| 12:44 ET | 500 | 46.47 |
| 12:48 ET | 600 | 46.44 |
| 12:50 ET | 100 | 46.51 |
| 12:51 ET | 1010 | 46.39 |
| 12:55 ET | 1447 | 46.38 |
| 12:57 ET | 1300 | 46.19 |
| 01:00 ET | 49013 | 46.22 |
Nov 14, 2024
Mirum Pharmaceuticals to Showcase Data from its LIVMARLI and Volixibat Clinical Programs at AASLD's The Liver Meeting, from 8:00AM ET on Thursday Nov 14, 2024 by Dow Jones
8:00AM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 13, 2024
DJ Mirum Pharmaceuticals Price Target Maintained With a $66.00/Share by HC Wainwright & Co., from 2:06PM ET on Wednesday Nov 13, 2024 by Dow Jones
2:06PM ET on Wednesday Nov 13, 2024 by Dow JonesDJ Mirum Pharmaceuticals Is Maintained at Buy by Citigroup, from 12:59PM ET on Wednesday Nov 13, 2024 by Dow Jones
12:59PM ET on Wednesday Nov 13, 2024 by Dow JonesDJ Mirum Pharmaceuticals Is Maintained at Outperform by Baird, from 7:32AM ET on Wednesday Nov 13, 2024 by Dow Jones
7:32AM ET on Wednesday Nov 13, 2024 by Dow Jones
Nov 12, 2024
*DJ Mirum Pharmaceuticals 3Q Loss/Shr 30c >MIRM, from 8:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
8:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mirum Pharmaceuticals Inc | 2.2B | -21.8x | --- |
WAVE Life Sciences Ltd | 2.3B | -13.6x | --- |
MannKind Corp | 1.8B | 95.3x | --- |
Xencor Inc | 1.8B | -8.0x | --- |
Vericel Corp | 2.9B | 751.6x | --- |
Dynavax Technologies Corp | 1.7B | 105.3x | --- |
Company Information
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the identification, acquisition, development and commercialization of therapies for debilitating rare and orphan diseases. It has three medicines: LIVMARLI (maralixibat) oral solution (Livmarli), Cholbam (cholic acid) capsules, and Chenodal (chenodiol) tablets. Livmarli is an orally administered, minimally-absorbed ileal bile acid transporter (IBAT) inhibitor (IBATi) that is used for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS) in the United States and various other countries and for cholestatic pruritus in patient with progressive familial intrahepatic cholestasis (PFIC) in the United States. Cholbam is used for the treatment of bile acid synthesis disorders due to single enzyme deficiencies and adjunctive treatment of peroxisomal disorders. It is also advancing its product candidate, volixibat, for the treatment of adult patients with cholestatic liver diseases.
Contact Information
- Headquarters
- 989 EAST HILLSDALE BOULEVARD, SUITE 300FOSTER CITY, CA, United States 94404
- Phone
- 650-667-4085
- Fax
- 302-269-3855
Executives
- Independent Non-Executive Chairman of the Board
- Michael Grey
- President, Chief Operating Officer
- Peter Radovich
- Chief Executive Officer, Co-Founder, Director
- Christopher Peetz
- Chief Financial Officer
- Eric Bjerkholt
- Chief Scientific Officer
- Pamela Vig
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.2B |
|---|---|
Revenue (TTM) | $307.0M |
Shares Outstanding | 48.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.20 |
EPS | $-2.12 |
Book Value | $5.32 |
P/E Ratio | -21.8x |
Price/Sales (TTM) | 7.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -31.26% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
